Hypertrophic cardiomyopathy with features of left ventricular non-compaction: How many diseases?
| Autor: | Marc L. Baker, Bruce I. Goldman, Michael W. Fong |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Dextromethorphan poisoning business.industry Hypertrophic cardiomyopathy Dextromethorphan medicine.disease Coricidin hbp Antitussive drugs Internal medicine Cardiology medicine Drug reaction Myocardial disease Cardiology and Cardiovascular Medicine business Consensus guideline medicine.drug |
| Zdroj: | International Journal of Cardiology. 148:364-366 |
| ISSN: | 0167-5273 |
| DOI: | 10.1016/j.ijcard.2010.09.026 |
| Popis: | [1] Chyka PA, Erdman AR, Manoguerra AS, et al. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Tox 2007;45:662–7. [2] Banerji S, Anderson IB. Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center. Am J Health Syst Pharm 2001;58(19):1811–4. [3] Miller SC. Dextromethorphan psychosis, dependence and physical withdrawal. Addict Biol 2005;10:325–7. [4] Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med 1995;13:174–6. [5] Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45. [6] Deisemann H, Ahrens N, Schlobohm I, et al. Effects of common antitussive drugs on the hERG Potassium Channel Current. J Cardiovasc Pharmacol 2008;52(6):494–9. [7] Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MCP. QTc interval screening and methadone treatment. Ann Intern Med 2009;150(6):387–95. [8] Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149–50. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect